Generate Biomedicines, Inc. (GENB)
$17.72+9.93%Close
BUY
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $2.3B
- Avg volume
- 737.6K
- Beta
- -0.14
- P/E (TTM)
- -19.08
- Short % float
- 13.22%
- Days to cover
- 15.3
- SI change
- +4.2%
- 1W
- +12.94%
- 1M
- +32.24%
- 3M
- +21.95%
- YTD
- +40.08%
- vs SPY 1W
- +14.13%
- vs SPY 1M
- +28.92%
- vs SPY 3M
- +19.56%
- vs SPY YTD
- +28.33%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- SYBXBUYSynlogic, Inc.RECOVERYQ -21$1.18-1.67%
- CTMXBUYCytomX Therapeutics, Inc.RECOVERYQ 8$3.29+0.30%
- MLSSBUYMilestone Scientific Inc.BEARQ 5$0.47-2.08%
- QDELSELLQuidelOrtho CorporationCRISISQ 8$14.49-1.70%
- SSIISELLSS Innovations International, Inc.RECOVERYQ 17$3.50-2.51%
- MXCTBUYMaxCyte, Inc.RECOVERYQ 13$1.39+0.72%
- ODTXBUYOdyssey Therapeutics, Inc.Q 80$25.15-4.70%
- DCGOSELLDocGo Inc.CRISISQ -29$0.38-11.63%
- HCATSELLHealth Catalyst, Inc.CRISISQ -17$1.59+3.92%
- KPTISELLKaryopharm Therapeutics Inc.CRISISQ -5$1.86-5.10%
- CGONBUYCG Oncology, Inc. Common stockBULLQ 32$78.23-1.98%
- LUCYBUYInnovative Eyewear, Inc.RECOVERYQ -17$1.12+64.71%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 5
- VALUE
- 3
- GROWTH
- 17
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-15.9%
REV YoY-
ROE-26.5%
EPS YoY-
ROA-22.9%
GROSS76
OP-1003
NET-951
[VALUATION]
P/E TTM-19.08
P/E FWD-
SECTOR PE22.62
INDUSTRY PE17.13
P/B5.69
P/FCF-
EV/EBITDA-22.13
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E13.73
ALTMAN Z-
CURR RATIO8.30
ND/EBITDA-
BETA-0.14
